Clinical trials

Interview

Preliminary Results From the DRASTICO Trial: A Discussion With Francesco Liistro, MD

02/09/2017

An interview with the principal investigator of the ongoing DRASTICO trial, which is comparing drug-eluting stent vs drug-eluting balloon in complex patients.

An interview with the principal...

02/09/2017

Vascular Disease Management

Preliminary Results From the DRASTICO Trial: A Discussion With Francesco Liistro, MD

02/09/2017

Jennifer Ford

An interview with the principal investigator of the ongoing DRASTICO trial, which is comparing drug-eluting stent vs drug-eluting balloon in complex patients.

An interview with the principal...

02/09/2017

Vascular Disease Management

Upper Torso Vibroacoustic Stimulation for Treatment of No-Reflow Following STEMI-Directed PPCI: A Device and Pilot Study Protocol — Shake, Rattle, and Rock`n Reflow!

12/08/2016

Arkady Uryash, MD¹, Harjit Gill, PhD², Andrew Hoffmann, BSc³
¹CEO, Parallel Biotechnologies LLC, Miami Beach, Florida; ²In-Vitro Laboratories, Burnaby, British Columbia, Canada; ³Ahof Biophysical Systems Inc., Burnaby, British Columbia, Canada.

Arkady Uryash, MD1, Harjit Gill, PhD2...

We present a prospective, double-blinded, randomized, controlled pilot study protocol to test whether tdVAS (50 Hz, 2mm), by 30-minute session directly following primary percutaneous coronary intervention, is feasible, safe, and may enhance...

We present a prospective,...

12/08/2016

Cath Lab Digest

News

Michigan Outpatient Vascular Institute on Cutting Edge of Peripheral Vascular Treatment Options

05/09/2016

News: Michigan Outpatient Vascular Institute, (Dearborn Michigan) recently became the first center in the state of Michigan to enroll subjects in the clinical trial (MIMICS-2) of an investigational nitinol stent for femoropopliteal artery...

News: Michigan Outpatient...

05/09/2016

Cath Lab Digest

Research in Review

Selection Criteria Barring Access to Clinical Trials for NSCLC Patients

01/15/2016

JCP Editors

Clinical trials for non–small cell lung cancer (NSCLC) are increasingly demanding tumor samples or research biopsies, which may bar participation and delay treatment for patients, a new study finds. The need for...

...

01/15/2016

Journal of Clinical Pathways